Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers
miRNA 癌症生物标志物的单分子高置信度检测
基本信息
- 批准号:10612611
- 负责人:
- 金额:$ 20.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-13 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibodiesAttentionBenchmarkingBindingBiologicalBiological AssayBiological MarkersBuffersCellsClinicalDNADNA SequenceDetectionDevelopmentDiagnosisDiagnostic Neoplasm StagingDiagnostic SpecificityDiseaseDisease ProgressionDyesEarly DiagnosisEnzymesExhibitsFaceFluorescenceFluorescence MicroscopyFluorescence Resonance Energy TransferGoalsHealthHourHumanLabelMalignant NeoplasmsMeasuresMethodologyMethodsMicroRNAsMicrofluidic MicrochipsMonitorMusMutationNatureNoiseNucleic AcidsPathway interactionsPatient-derived xenograft models of breast cancerPatientsPhysiologyPoint MutationProcessPrognosisRNA SequencesRecurrenceReproducibilityResearchResourcesRiskRisk AssessmentRoleSamplingSchemeScreening for cancerSerumSignal TransductionSpeedStagingTP53 geneTechniquesTechnologyTestingTherapeuticTranslatingTumor Suppressor GenesTumor TissueUncertaintyWorkcancer biomarkerscancer diagnosiscancer therapycirculating microRNAclinical applicationclinical diagnosisclinical practicecostdesigndetection assaydetection methoddetection platformdetection sensitivityfluorophorehuman diseaseinnovationinterestmiRNA expression profilingmicroRNA biomarkersmultiplex detectionmutantnovel strategiesoverexpressionpatient derived xenograft modelpre-clinicalresponsesensorsingle cell technologysingle moleculesynthetic constructtechnology platformtreatment responsetriple-negative invasive breast carcinomatumortumor growthtumor xenograft
项目摘要
Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers
PROJECT SUMMARY/ ABSTRACT
The ultimate goal of this proposal is to develop a technology platform for high confidence and robust single
molecule analysis of miRNA biomarkers in cancer samples through simultaneous detection of miRNAs, in
under an hour. Although miRNAs are short, they regulate essentially all cellular pathways relevant to human
health and disease, including cancer. After being exported from cells, the cell-free circulating miRNAs are
found to be relatively more stable than other nucleic acids, making them of high interest as clinical cancer
biomarkers. Current methods for miRNA analysis, including PCR assays, face challenges due to inherent
inconsistencies in day-to-day and lab-to-lab results in addition to false negatives and positives. We have
recently developed a unique fluorescence resonance energy transfer (FRET)-based single molecule dynamic
sensor to enable high confidence and ultrasensitive detection of an unlabeled DNA as well as miRNA targets
and demonstrated that the sensing platform works in serum and fully discriminates targets from point mutant
controls. Using total internal reflection fluorescence microscopy, we demonstrated that the sensor exhibits a
static FRET level in the absence of a target. However, in the presence of the target, the sensor forms a four-
way junction and hence undergoes a dynamic switching between a low- and a high-FRET state, a feature
that enables high-confidence detection of the target. We demonstrated these features initially using a p53
tumor suppressor gene and later a miRNA associated with the triple-negative breast cancer (TNBC), both in
buffer and in spiked-in samples using 10% serum. In this proposal, we will focus on the development and
testing of this platform for high-confidence detection through multiplexed analysis of miRNAs in non-clinical
as well as minimally processed cancer samples. In Aim 1, we will design and characterize a sensing platform
for the detection of DNA sequences in one sample. In Aim 2, we will characterize and validate the detection
platform for simultaneous detection of miRNAs specific to TNBC. We will also establish a speedy detection
of TNBC miRNAs using a microfluidic device with parallel channels. In Aim 3, we will identify the abundant
miRNAs in tumor tissues and serum samples of TNBC-carrying patient-derived xenograft (PDX) mice via
miRNA sequencing and apply our single-molecule multiplexed platform to detect those TNBC miRNAs in
serum samples from the PDX mice. Our proposed approach offers a number of important innovations
including i) a generic platform for error-free detection of miRNAs, ii) ultimate sensitivity via single-molecule
detection, iii) simultaneous detection of multiple biomarkers in the same sample - allowing high-confidence
detection, and iv) target labeling and amplification are not required. Therefore, this multiplexed platform has
the potential to be a transformative technology in the early diagnosis of cancer. By providing detection
sensitivity and confidence that meets or exceeds state-of-the-art clinical analyzers, the proposed approach
could bring new initiatives in clinical diagnosis, cancer assessment, and individualized cancer treatments.
miRNA肿瘤标志物的单分子高置信度检测
项目总结/摘要
本提案的最终目标是开发一个技术平台,用于高置信度和鲁棒性的单
通过同时检测miRNA,对癌症样品中的miRNA生物标志物进行分子分析,
不到一小时。尽管miRNAs很短,但它们基本上调节与人类免疫相关的所有细胞通路。
健康和疾病,包括癌症。从细胞中输出后,无细胞循环miRNA被
被发现比其他核酸相对更稳定,使得它们作为临床癌症受到高度关注。
生物标志物。目前用于miRNA分析的方法,包括PCR测定,由于固有的缺陷而面临挑战。
除了假阴性和假阳性之外,日常和实验室之间的结果不一致。我们有
最近开发了一种独特的基于荧光共振能量转移(FRET)的单分子动态
传感器,能够高置信度和超灵敏度检测未标记的DNA以及miRNA靶标
并证明该传感平台在血清中工作,并完全区分目标和点突变体
对照使用全内反射荧光显微镜,我们证明了传感器具有
在不存在靶标的情况下的静态FRET水平。然而,在目标存在的情况下,传感器形成四个-
因此,在低FRET状态和高FRET状态之间经历动态切换,
这使得能够高置信度地检测目标。我们最初使用p53
肿瘤抑制基因和后来与三阴性乳腺癌(TNBC)相关的miRNA,两者都在
缓冲液和使用10%血清的加标样品中。在本建议中,我们将重点关注发展和
通过对非临床应用中的miRNA进行多重分析,测试该平台的高置信度检测。
以及最低限度处理的癌症样本。在目标1中,我们将设计和表征传感平台
用于检测一个样本中的DNA序列。在目标2中,我们将描述和验证检测
用于同时检测特异于TNBC的miRNA的平台。我们还将建立一个快速检测
使用具有平行通道的微流体装置,在目标3中,我们将确定丰富的
携带TNBC的患者来源的异种移植物(PDX)小鼠的肿瘤组织和血清样品中的miRNA,
miRNA测序并应用我们的单分子多重平台来检测TNBC中的miRNA
来自PDX小鼠的血清样品。我们提出的方法提供了一些重要的创新
包括i)用于无错误检测miRNA的通用平台,ii)通过单分子检测的最终灵敏度,
检测,iii)同时检测同一样品中的多种生物标志物-允许高置信度
检测和iv)不需要靶标记和扩增。因此,该多路复用平台具有
有可能成为癌症早期诊断的变革性技术。通过提供检测
达到或超过最先进的临床分析仪的灵敏度和置信度,
可以在临床诊断、癌症评估和个体化癌症治疗方面带来新的举措。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Soma Dhakal其他文献
Soma Dhakal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别: